aTYR PHARMA (ATYR) Return on Sales [ROS] (2019 - 2026)
aTYR PHARMA (ATYR) posted Return on Sales [ROS] of -38573.68% for Q1 2026, up 2282.63 percentage points from the prior quarter.
Powered by 
Analysis
aTYR PHARMA (ATYR) Return on Sales [ROS] (2019 - 2026) Analysis & Trends
For FY2025, aTYR PHARMA's Return on Sales [ROS] came in at -40856.32%, down 11956.74 percentage points from FY2024.
- Annual Return on Sales [ROS] has declined for three consecutive years, with a five-year change of -40704.13 percentage points (FY2020 to FY2025).
- In prior years, aTYR PHARMA's Return on Sales [ROS] was -28899.57% in FY2024 (-13341.78 pp), -15557.79% in FY2023 (-15111.00 pp) and -446.79% in FY2022.
- Quarterly Return on Sales [ROS] has run from a low of -40856.32% in Q4 2025 to a high of -76.55% in Q4 2022 over five years.
- On a year-over-year basis, Return on Sales [ROS] increased in 1 of the last five quarters, with an average year-over-year change of -9194.92 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q3 2025, with a gain of 14882.41 percentage points; the weakest was Q3 2024, with a drop of 25385.07 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 28.37% |
| 10 | aTYR PHARMA | 16.67 Mn | -276.34 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -38,573.68% |
| Dec 31, 2025 | -40,856.32% |
| Sep 30, 2025 | -14,076.32% |
| Dec 31, 2024 | -28,899.57% |
| Sep 30, 2024 | -28,958.72% |
| Jun 30, 2024 | -10,633.50% |
| Mar 31, 2024 | -7,079.15% |
| Dec 31, 2023 | -15,557.79% |
| Sep 30, 2023 | -3,573.65% |
| Jun 30, 2023 | -460.11% |
| Mar 31, 2023 | -450.73% |
| Dec 31, 2022 | -76.55% |
| Sep 30, 2022 | -2,139.66% |
| Mar 31, 2022 | -1,639.79% |
| Dec 31, 2020 | -240.62% |
| Sep 30, 2020 | -4,400.00% |
| Jun 30, 2020 | -3,342.86% |
| Mar 31, 2020 | 23.05% |
| Dec 31, 2019 | -4,140.28% |
| Sep 30, 2019 | -2,988.04% |
API Access
aTYR PHARMA Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ATYR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ATYR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ATYR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();